Literature DB >> 23567795

A case of life-threatening retinoic acid syndrome and review of literature.

Zeeshan Tariq1, Richard C Phinney, Iman Mohamed.   

Abstract

All-trans-retinoic acid represents a major progress that has made acute promyelocytic leukemia the most curable subtype of acute myeloid leukemia in adults. Although all-trans-retinoic acid is usually well tolerated, some patients develop the retinoic acid syndrome, characterized by unexplained fever, weight gain, respiratory distress, interstitial pulmonary infiltrates, pleural and pericardial effusions, episodic hypotension, and acute renal failure. Further studies of growth factor expression and modulation of adhesion molecules are warranted to provide further insights into the pathogenesis of the syndrome and may lead to its prevention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23567795     DOI: 10.1097/MJT.0b013e31822aeece

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  2 in total

1.  Retinoid Chemoprevention: Who Can Benefit?

Authors:  Rodica P Bunaciu; Andrew Yen
Journal:  Curr Pharmacol Rep       Date:  2015-04-15

2.  Multi-species transcriptome meta-analysis of the response to retinoic acid in vertebrates and comparative analysis of the effects of retinol and retinoic acid on gene expression in LMH cells.

Authors:  Clemens Falker-Gieske; Andrea Mott; Sören Franzenburg; Jens Tetens
Journal:  BMC Genomics       Date:  2021-03-02       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.